|
2024
|
Invention
|
Method for preparing chiral alcohol compound. Disclose in the present invention is a method for p... |
|
|
Invention
|
Cdk12/13 covalent inhibitors or pharmaceutical composition thereof, and uses thereof.
The presen... |
|
|
Invention
|
Deuterated diaryl glycoluril tetramer compound and use thereof. Disclosed are a deuterated glycol... |
|
|
Invention
|
Cyclic 2-aminopyrimidine compound and pharmaceutical composition and use thereof. Provided are a ... |
|
|
Invention
|
Anti-tumor use of r406 and derivative thereof in synergy with trail. Provided are a series of com... |
|
|
Invention
|
Nsd protein degradation agent and use thereof. The present invention provides an NSD protein degr... |
|
|
Invention
|
Class of programmed cell death inhibitors, preparation method therefor and use thereof. The prese... |
|
|
Invention
|
Polycyclic compounds as kinase inhibitors, preparation method therefor, and use thereof. The pres... |
|
|
Invention
|
Compound, and preparation method therefor and use thereof. 0123455 is selected from at least one ... |
|
|
Invention
|
Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide cou... |
|
|
Invention
|
Pikfyve protein kinase degradation agent and use thereof. A PIKfyve protein degradation agent and... |
|
|
Invention
|
Phosphine ligands and use thereof in carbonylation of acetylene/ethylene to synthesize acrylate/p... |
|
|
Invention
|
Aryl substituent-containing degradation agent for cdk12/13, preparation method therefor, and phar... |
|
|
Invention
|
Polycyclic compound for treating neurological diseases and tumors. Disclosed in the present inven... |
|
|
Invention
|
Hpk1 inhibitor, and preparation method therefor and use thereof. Provided in the present inventio... |
|
2023
|
Invention
|
Cyclic compounds used as multi-target kinase inhibitors and preparation method therefor. Disclose... |
|
|
Invention
|
Non-bipyridyl salt herbicide, preparation method therefor, and use thereof. Disclosed are a non-b... |
|
|
Invention
|
Pyridopyrimidine-based compound and application thereof.
The present disclosure provides a class... |
|
|
Invention
|
Use of mif and ripk1 in perioperative ischemic brain injuries. Provided in the present invention ... |
|
|
Invention
|
Synthesis of amide compound and use thereof. The present invention relates to a novel oleanamide ... |
|
|
Invention
|
Chemical-enzyme coupling method for synthesizing ergothioneine. Provided is a chemical-enzyme cou... |
|
|
Invention
|
Recyclable high-reactivity hypervalent iodine reagent. The present invention provides a recyclabl... |
|
2022
|
Invention
|
Benzo[c]cinnoline skeleton diimide ligand and preparation method therefor. Disclosed in the prese... |
|
|
Invention
|
Method for preparing sulphur-containing polymer based on isomerisation-driven irreversible ring-o... |
|
|
Invention
|
Preparation method for 1,3-disubstituted allene compound at room temperature based on metal carbe... |
|
|
Invention
|
Compounds that inhibit necroptosis and their preparation methods.
RIPK1 inhibitors for inhibitin... |
|
|
Invention
|
Compound that inhibits programmed cell necrosis, and preparation method therefor. Disclosed are a... |
|
|
Invention
|
3, 3-difluoroallylic onium salt compound and preparation method therefor and application thereof.... |
|
|
Invention
|
Application of glun2a and nmda receptor containing glun2a as targets in screening drugs for treat... |
|
|
Invention
|
Protein kinase degradant and use thereof. The present invention provides a protein kinase degrada... |
|
|
Invention
|
Method for synthesizing molecular glass, and use thereof as high-frequency low-dielectric-constan... |
|
|
Invention
|
Nmda receptor antagonist and use thereof. 22 are as described herein. The present invention also ... |
|
|
Invention
|
Compound for inhibiting programmed cell death and preparation method therefor. Disclosed in the p... |
|
|
Invention
|
Method for preparing antibody-drug conjugate. 22) group or modified with a hydroxylamine group, a... |
|
|
Invention
|
Inhibitors for programmed cell necrosis and preparation method therefor and use thereof.
Provide... |
|
|
Invention
|
Pyridopyrimidine-based compound and application thereof. Provided are a pyridopyrimidine-based co... |
|
|
Invention
|
Fused tricyclic compounds as rip1-kinase inhibitors and uses thereof. A compound of formula I bel... |
|
|
Invention
|
Heteroaryl-fused bicyclic compound as rip1-kinase inhibitors and uses thereof. A compound of form... |
|
2021
|
Invention
|
Method for capturing modified nucleic acid and application thereof. A method for capturing a modi... |
|
|
Invention
|
Diaryl-b-lactam compound and preparation method and pharmaceutical use thereof.
The present inve... |
|
|
Invention
|
Programmed cell necrosis inhibitor, preparation method therefor, and use thereof.
The present in... |
|
|
Invention
|
Programmed cell necrosis inhibitor, preparation method therefor, and use thereof. The present inv... |
|
|
Invention
|
Low-bulk-density ultra-high-molecular-weight polyethylene micropowder. Provided is ultra-high-mol... |
|
|
Invention
|
Siloxane having low dielectric constant and loss at high frequencies, and preparation method ther... |
|
|
Invention
|
Glucose triptolide conjugates and uses thereof.
A major hurdle in the treatment of cancer is che... |
|
2020
|
Invention
|
Polymer impurity removal method based on steam distillation.
The present invention provides a me... |
|
|
Invention
|
Class of phosphine nitrogen ligand with multiple chiral centers and its synthesis method and appl... |
|
2019
|
Invention
|
Metal complex, intermediate, and preparation method and application thereof. Provided is a metal ... |
|
|
Invention
|
Pharmaceutical composition for treatment of neurodegenerative diseases or diseases caused by abno... |
